TRCT
LFVN icon

Tower Research Capital (TRC)’s LifeVantage LFVN Stock Holding History

Tower Research Capital (TRC)’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.3K Buy
4,226
+2,542
+151% +$13.3K ﹤0.01% 3541
2025
Q4 		$10.4K Buy
1,684
+932
+124% +$6.9K ﹤0.01% 3786
2025
Q3 		$7.32K Buy
752
+717
+2,049% +$8.98K ﹤0.01% 4102
2025
Q2 		$458 Buy
35
+31
+775% +$401 ﹤0.01% 5020
2025
Q1 		$58 Sell
4
-707
-99% -$13.3K ﹤0.01% 5068
2024
Q4 		$12.5K Sell
711
-198
-22% -$2.78K ﹤0.01% 3614
2024
Q3 		$11K Buy
909
+409
+82% +$3.39K ﹤0.01% 3704
2024
Q2 		$3.21K Buy
500
+474
+1,823% +$3.21K ﹤0.01% 4921
2024
Q1 		$157 Sell
26
-571
-96% -$3.61K ﹤0.01% 5615
2023
Q4 		$3.58K Buy
+597
New +$3.95K ﹤0.01% 5059
2023
Q3 		– Sell
-3,895
Closed -$16.9K – 6111
2023
Q2 		$16.9K Sell
3,895
-7,283
-65% -$30.1K ﹤0.01% 3534
2023
Q1 		$40K Sell
11,178
-4,482
-29% -$16.8K ﹤0.01% 2711
2022
Q4 		$58K Buy
15,660
+4,298
+38% +$16.4K ﹤0.01% 2240
2022
Q3 		$42K Buy
11,362
+6,138
+117% +$24.8K ﹤0.01% 3318
2022
Q2 		$23K Buy
5,224
+4,990
+2,132% +$21.8K ﹤0.01% 3654
2022
Q1 		$1K Sell
234
-392
-63% -$2.18K ﹤0.01% 5813
2021
Q4 		$4K Sell
626
-915
-59% -$6.23K ﹤0.01% 5322
2021
Q3 		$10K Sell
1,541
-1,505
-49% -$11.1K ﹤0.01% 4324
2021
Q2 		$23K Buy
3,046
+1,145
+60% +$9.35K ﹤0.01% 3760
2021
Q1 		$17K Sell
1,901
-3,542
-65% -$33K ﹤0.01% 4009
2020
Q4 		$50K Sell
5,443
-10,794
-66% -$121K ﹤0.01% 3127
2020
Q3 		$196K Buy
16,237
+13,169
+429% +$178K ﹤0.01% 2594
2020
Q2 		$41K Buy
3,068
+2,968
+2,968% +$41.2K ﹤0.01% 3205
2020
Q1 		$1K Sell
100
-2,692
-96% -$36.9K ﹤0.01% 2795
2019
Q4 		$43K Buy
2,792
+374
+15% +$5.5K ﹤0.01% 1437
2019
Q3 		$33K Buy
2,418
+357
+17% +$4.35K ﹤0.01% 2101
2019
Q2 		$26K Buy
2,061
+531
+35% +$6.31K ﹤0.01% 2007
2019
Q1 		$22K Buy
1,530
+735
+92% +$10.7K ﹤0.01% 2214
2018
Q4 		$10K Buy
795
+450
+130% +$5.38K ﹤0.01% 2469
2018
Q3 		$4K Sell
345
-16,122
-98% -$172K ﹤0.01% 3198
2018
Q2 		$105K Buy
16,467
+5,085
+45% +$23.2K 0.01% 1403
2018
Q1 		$41K Buy
11,382
+3,157
+38% +$13.4K ﹤0.01% 1781
2017
Q4 		$39K Buy
+8,225
New +$43.2K 0.01% 1531
2017
Q3 		– Sell
-2,890
Closed -$13K – 3996
2017
Q2 		$13K Buy
2,890
+2,679
+1,270% +$11.8K ﹤0.01% 1455
2017
Q1 		$1K Sell
211
-2,717
-93% -$17.1K ﹤0.01% 2807
2016
Q4 		$23K Buy
2,928
+2,005
+217% +$17.1K ﹤0.01% 2014
2016
Q3 		$9K Buy
+923
New +$12K ﹤0.01% 2141
2016
Q2 		– Sell
-208
Closed -$2K – 4722
2016
Q1 		$2K Sell
208
-1,991
-91% -$17.7K ﹤0.01% 3396
2015
Q4 		$21K Buy
+2,199
New +$16.6K ﹤0.01% 1243
2015
Q1 		– Sell
-142
Closed -$1K – 4694
2014
Q4 		$1K Sell
142
-788
-85% -$7.23K ﹤0.01% 3668
2014
Q3 		$7K Sell
930
-726
-44% -$6.66K ﹤0.01% 3070
2014
Q2 		$17K Sell
1,656
-1,189
-42% -$11.3K ﹤0.01% 1933
2014
Q1 		$26K Buy
+2,845
New +$28.5K ﹤0.01% 1647
2013
Q4 		– Sell
-732
Closed -$12K – 4719
2013
Q3 		$12K Buy
732
+444
+154% +$7.67K ﹤0.01% 3083
2013
Q2 		$5K Buy
+288
New +$4.62K ﹤0.01% 2934

Other funds holding LFVN

CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Tower Research Capital (TRC)'s LFVN Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its LifeVantage (LFVN) stake by 151% in Q1 2026, buying an estimated $13.3K and bringing the position to 4,226 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3541.

Tower Research Capital (TRC) first reported a position in LFVN in Q2 2013 and has held it in 45 quarters since. The position peaked at $196K in Q3 2020. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

  • Tower Research Capital (TRC) held 4,226 shares of LifeVantage worth $18.3K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,542 LifeVantage shares in Q1 2026, an estimated $13.3K.
  • LifeVantage made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3541 holding.
  • Tower Research Capital (TRC) first reported a position in LifeVantage in Q2 2013 and has held it in 45 quarters since.
  • Tower Research Capital (TRC)'s LifeVantage position peaked at $196K in Q3 2020.
  • 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.